DST-backed researchers from Pune demonstrate targeted gene-silencing approach that significantly inhibits tumor growth with minimal toxicity
This positions its platform as a rapidly evolving engine for next-generation genetic medicine
Funding to support clinical development, gene therapy pipeline expansion and GMP manufacturing capabilities
The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
Under the new policy, financial assistance has been increased to Rs 50 lakh per patient to improve treatment access
Strong CDMO growth, improved product mix and operational leverage drive profitability expansion
On his visit to NIPER Mohali, union health minister vreviews biopharma research initiatives and calls for stronger industry collaboration and commercialization focus
Union health minister urges graduates in Chandigarh to combine technological excellence with compassion in medical practice
In his new role, Gregory will drive partnerships for the company’s large-scale molecule biologics business across Europe
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
